Skip to main content

Full Schedule

Full Schedule

16 results found

  • Saturday, September 30, 2023
  • 8:00 AM – 8:15 AM ET
    Welcome
    Co-Chair: Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center
    Co-Chair: David H. Ilson, MD, PhD – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
  • 8:15 AM – 8:50 AM ET
    Session 17: Updates from Recent Meetings
    Presenter: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
  • 8:50 AM – 9:00 AM ET
    Live Q&A
    Moderator: Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center
    Moderator: David H. Ilson, MD, PhD – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
    Panelist: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
  • 9:00 AM – 9:35 AM ET
    Session 18: Novel Newer and Emerging Treatment Options for the Management of Non-MSI-H Metastatic Colorectal Cancer
    Presenter: Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center
  • 9:35 AM – 9:45 AM ET
    Live Q&A
    Moderator: Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center
    Moderator: David H. Ilson, MD, PhD – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
  • 9:45 AM – 9:50 AM ET
    Break
  • 9:50 AM – 10:50 AM ET
    Non-CME Innovation Theater (Sponsored By Taiho Oncology)
  • 10:50 AM – 11:20 AM ET
    Exhibit Hall
  • 11:20 AM – 11:35 AM ET
    Session 19: Debate: NALIRIFOX or FOLFIRINOX for Treatment-Naive Metastatic Pancreatic Cancer - FOLFIRINOX
    Presenter: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
  • 11:35 AM – 11:50 AM ET
    Session 19: Debate: NALIRIFOX or FOLFIRINOX for Treatment-Naive Metastatic Pancreatic Cancer - NALIRIFOX
    Presenter: Milind M. Javle, MD – MD Anderson Cancer Center, The University of Texas
  • 11:50 AM – 12:05 PM ET
    Session 19: Debate: NALIRIFOX or FOLFIRINOX for Treatment-Naive Metastatic Pancreatic Cancer - Discussion
    Moderator: Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center
    Moderator: David H. Ilson, MD, PhD – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
    Panelist: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
    Panelist: Milind M. Javle, MD – MD Anderson Cancer Center, The University of Texas
  • 12:05 PM – 12:35 PM ET
    Lunch
  • 12:35 PM – 1:10 PM ET
    Session 20: Significance of Cancer Genetics
    Presenter: Sonia Kupfer, MD – University of Chicago
  • 1:10 PM – 1:20 PM ET
    Live Q&A
    Moderator: Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center
    Moderator: David H. Ilson, MD, PhD – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
    Panelist: Sonia Kupfer, MD – University of Chicago
  • 1:20 PM – 1:55 PM ET
    Session 21: Rising Incidence of Early-Onset GI Malignancies: Pancreatic, CRC, and Gastric
    Presenter: Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center
  • 1:55 PM – 2:05 PM ET
    Live Q&A
    Moderator: David H. Ilson, MD, PhD – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
    Presenter: Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center
Back to Top